These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23347430)

  • 1. Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells.
    Sanders DA; Ross-Innes CS; Beraldi D; Carroll JS; Balasubramanian S
    Genome Biol; 2013 Jan; 14(1):R6. PubMed ID: 23347430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.
    Millour J; Constantinidou D; Stavropoulou AV; Wilson MS; Myatt SS; Kwok JM; Sivanandan K; Coombes RC; Medema RH; Hartman J; Lykkesfeldt AE; Lam EW
    Oncogene; 2010 May; 29(20):2983-95. PubMed ID: 20208560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells.
    Madureira PA; Varshochi R; Constantinidou D; Francis RE; Coombes RC; Yao KM; Lam EW
    J Biol Chem; 2006 Sep; 281(35):25167-76. PubMed ID: 16809346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells.
    Bergamaschi A; Madak-Erdogan Z; Kim YJ; Choi YL; Lu H; Katzenellenbogen BS
    Breast Cancer Res; 2014 Sep; 16(5):436. PubMed ID: 25213081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index.
    Yau C; Meyer L; Benz S; Vaske C; Scott G; Egan B; Labhart P; Pourmand N; Benz CC
    Breast Cancer Res Treat; 2015 Nov; 154(1):23-32. PubMed ID: 26456572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancer.
    Horimoto Y; Hartman J; Millour J; Pollock S; Olmos Y; Ho KK; Coombes RC; Poutanen M; Mäkelä SI; El-Bahrawy M; Speirs V; Lam EW
    Am J Pathol; 2011 Sep; 179(3):1148-56. PubMed ID: 21763263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation independent eIF4E translational reprogramming of selective mRNAs determines tamoxifen resistance in breast cancer.
    Gong C; Tsoi H; Mok KC; Cheung J; Man EPS; Fujino K; Wong A; Lam EWF; Khoo US
    Oncogene; 2020 Apr; 39(15):3206-3217. PubMed ID: 32066877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
    Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW
    Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.
    Al-Dhaheri M; Wu J; Skliris GP; Li J; Higashimato K; Wang Y; White KP; Lambert P; Zhu Y; Murphy L; Xu W
    Cancer Res; 2011 Mar; 71(6):2118-28. PubMed ID: 21282336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PELP1 oncogenic functions involve CARM1 regulation.
    Mann M; Cortez V; Vadlamudi R
    Carcinogenesis; 2013 Jul; 34(7):1468-75. PubMed ID: 23486015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness.
    Sisci D; Maris P; Cesario MG; Anselmo W; Coroniti R; Trombino GE; Romeo F; Ferraro A; Lanzino M; Aquila S; Maggiolini M; Mauro L; Morelli C; Andò S
    Cell Cycle; 2013 Nov; 12(21):3405-20. PubMed ID: 24047697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex.
    Gao WW; Xiao RQ; Zhang WJ; Hu YR; Peng BL; Li WJ; He YH; Shen HF; Ding JC; Huang QX; Ye TY; Li Y; Liu ZY; Ding R; Rosenfeld MG; Liu W
    Mol Cell; 2018 Apr; 70(2):340-357.e8. PubMed ID: 29628309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis.
    Bergamaschi A; Christensen BL; Katzenellenbogen BS
    Breast Cancer Res; 2011 Jun; 13(3):R70. PubMed ID: 21707964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.
    Millour J; de Olano N; Horimoto Y; Monteiro LJ; Langer JK; Aligue R; Hajji N; Lam EW
    Mol Cancer Ther; 2011 Jun; 10(6):1046-58. PubMed ID: 21518729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast Cancer Cells.
    Erdős E; Bálint BL
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha.
    Frietze S; O'Geen H; Littlepage LE; Simion C; Sweeney CA; Farnham PJ; Krig SR
    BMC Genomics; 2014 Jun; 15(1):520. PubMed ID: 24962896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA sequencing of MCF-7 breast cancer cells identifies novel estrogen-responsive genes with functional estrogen receptor-binding sites in the vicinity of their transcription start sites.
    Yamaga R; Ikeda K; Horie-Inoue K; Ouchi Y; Suzuki Y; Inoue S
    Horm Cancer; 2013 Aug; 4(4):222-32. PubMed ID: 23526455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.